Day 1 Highlights from ASH 2024: Breakthroughs in Sickle Cell Disease and ITP

Curie: Healthcare in Focus
09/12/2024 5 min Temporada 1 Episodio 3
Day 1 Highlights from ASH 2024: Breakthroughs in Sickle Cell Disease and ITP

Listen "Day 1 Highlights from ASH 2024: Breakthroughs in Sickle Cell Disease and ITP"

Descargar episodio Ver en sitio original

Episode Synopsis

Day 1 of ASH 2024 brought exciting advancements in hematology. In this episode, we explore highlights from pivotal trials, including etavopivat’s impact on sickle cell disease, rilzabrutinib’s rapid platelet response in ITP, and hydroxyurea’s benefits for HbSC patients. Hosted by Matt, this podcast offers clear insights into the research shaping tomorrow’s treatments.Love what you hear? Download the Curie app for daily updates and bonus episodes tailored for oncology professionals.

More episodes of the podcast Curie: Healthcare in Focus

The Preconception Revolution with Dr. Ann Shippy 04/11/2025
From Breakdown to Breakthrough - A Physician’s Reckoning with Burnout 28/10/2025
The Wellness Industrial Complex: What Influencers Reveal About Modern Medicine 21/10/2025
Autopilot Medicine: The Danger of Getting Too Good at AI 14/10/2025
Tylenol & Autism: What Clinicians Should Know (and Watch For) 07/10/2025
Replaceable You – Mary Roach on the Miracles We Can’t Copy 30/09/2025
The Great American Healthcare Heist with Chris Deacon 23/09/2025
From Bedside to Boardroom - Krista Bragg on Bridging Clinician and Executive Perspectives 16/09/2025
AI Scribes – The Hidden Cost of Progress 09/09/2025
Dr. Nasser Hanna - A Life in Medicine, Mentorship, and Advocacy 26/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA